Abstract
Leishmaniasis is a neglected disease of high incidence in many countries, including Brazil. There are few effective chemotherapeutic agents against this disease, therefore, is urgent the search for better therapeutic agents. On the other hand, prodrug design is a molecular modification process that, by means of carriers, allows the improvement of drug or bioactive compounds activity. Conc…